Seminars in Oncology
Volume 36, Issue 3 , Pages 194-206, June 2009

Cancer in Young Adults 20 to 39 Years of Age: Overview

  • Archie Bleyer

      Affiliations

    • St. Charles Medical Center, Bend, OR; Oregon Health and Science University, Portland, OR; and CureSearch/National Childhood Cancer Foundation, Arcadia, CA
    • Corresponding Author InformationAddress correspondence to Archie Bleyer, MD, 2884 NW Horizon Dr, Bend OR 97701
  • ,
  • Ronald Barr

      Affiliations

    • McMaster Children's Hospital; and Departments of Pediatrics, Pathology and Medicine, McMaster University, Hamilton, Ontario, Canada

Among 20- to 39-year-olds, cancer causes more deaths than any other disease except depression that culminates in suicide. More females in the age group die of cancer than of the next three causes combined. Yet, substantially less attention has been given to young adults than to children and older adults, and the relative improvement in the survival rate in young adults has not kept pace with that achieved in younger or older patients. Additionally, there is evidence that a substantial proportion of the cancers in young adults have a different biology, and probably etiology/pathogenesis, than that of what appears to be the same cancer in younger or older persons. The challenges of early detection, diagnosis, treatment, and follow-up are therefore likely to be distinctly different than in persons of a different age. As an introduction to this Seminars in Oncology issue on young adults with malignant disease, this overview summarizes cancer epidemiology, risk factors, survival, racial/ethnic and gender differences, diagnostic and treatment approaches, psychosocial challenges, and current organizational research and supportive care strategies in young adults.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by a grant from the Aflac Insurance Co to the National Childhood Cancer Foundation.

PII: S0093-7754(09)00038-4

doi:10.1053/j.seminoncol.2009.03.003

Seminars in Oncology
Volume 36, Issue 3 , Pages 194-206, June 2009